"Final Big Market Cap Event Of Year": All Eyes On Novo's CagriSema GLP-1 Results

Dec 17th 2024 1:40pm EST

“Final Big Market Cap Event Of Year”: All Eyes On Novo’s CagriSema GLP-1 Results The next big market cap event for Novo Nordisk is the top-line efficacy results for its experimental obesity drug, CagriSema, with data from a late-stage trial expected by the end of the year.  Novo previously stated that CagriSema could potentially lead to 25% weight […]

Discuss on Nostr!

Nostr Note ID note183dd2k06pv6kdsnvcps2e4v498lwsdtd9l7ajctescfg5wmga9eqdn7pef Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social

New to Nostr?
Create an account now & join the conversation!

Promote it on DissentWatch!

  • To advertise this post for $0.02 per visit send bitcoins to the address below
  • The post will be promoted daily via social media & our "Featured News" display in multiple places
  • You can add more anytime
  • Ranking order in the Featured News box is based on the balance remaining


Received: 0 mBTC (0.00 USD)

Spent: 0 mBTC (0.00 USD)

Balance: 0 mBTC (0.00 USD)

The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.

REFRESH AMOUNTS